CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

When, where, and how to target vascular inflammation in the post-CANTOS era? Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) MINOCA: a heterogenous group of conditions associated with myocardial damage Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Endocardium Minimally Contributes to Coronary Endothelium in the Embryonic Ventricular Free Walls Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials

Original Research2019 Feb 12;139(7):965-980.

JOURNAL:Circulation. Article Link

Circadian-Regulated Cell Death in Cardiovascular Diseases

Rabinovich-Nikitin I, Lieberman B, Martino TA et al. Keywords: biology; cardiovascular diseases; circadian rhythm; ischemia; science; translational medical research

FULL TEXT PDF